Why Glaxo isn’t meeting with Mayor Kenney while he’s in London

GSK declined the meeting with Mayor Kenney after a City Council bill was submitted that would force drugmakers to register their sales reps. Is there a connection?

Pharmacy benefit managers defend their Medicaid role at Pa. Senate committee hearing

The companies that negotiate drug prices answered pointed questions about costs and where the money is going.

Pharmacy benefit managers defend their Medicaid role at Pa. Senate committee hearing

The companies that negotiate drug prices answered pointed questions about costs and where the money is going.

Is Pa. getting shortchanged on drug costs? Legislators want to know.

A state senate hearing on Tuesday will focus on what taxpayers get from pharmacy benefit managers.

Is Pa. getting shortchanged on drug costs? Legislators want to know.

A state senate hearing on Tuesday will focus on what taxpayers get from pharmacy benefit managers.

Spark Therapeutics pledges 500 new jobs in move to first project in Schuylkill Yards plan

Spark Therapeutics is seeking a larger facility on Market Street in Drexel University's Schuylkill Yards development project.

Spark Therapeutics pledges 500 new jobs in move to first project in Schuylkill Yards plan

Spark Therapeutics is seeking a larger facility on Market Street in Drexel University's Schuylkill Yards development project.
More Stories

Blockchain hype may finally turn into reality in pharmaceuticals

A little-noticed U.S. law could bring the ledger system to the pharmaceutical business.

Philly's U.S. attorney going after white collar crime with '100 percent support' from Jeff Sessions

U.S. Attorney William McSwain lays out his plans to pursue white collar crime — with jail time attached.

Canadian marijuana firm Tilray gets rare DEA approval for clinical study

The U.S. Drug Enforcement Agency this morning granted approval to Tilray, Inc. to import research-grade marijuana products from Canada for a clinical trial at the University of California San Diego.

Chinese American scientist admits plot to steal GlaxoSmithKline’s secrets for firm in China

The case is the latest in a string of recent prosecutions of Chinese American scientists accused of purloining trade secrets from U.S. companies in hopes of bolstering China's competitive edge.

The future of medicine may land within five to 10 years, pioneering researcher says

A pioneer of the Crispr gene-editing technology that's taken Wall Street by storm says she's optimistic about their prospects of therapies.

Is pharma getting greedier?

There has been considerable consumer and policymaker concern about the rising prices of some prescription drugs, from the thousands-percent increases in the price of generics like Turing Pharmaceuticals' Daraprim to the average 8.8% increase by Pfizer for a large sample of its brand name drugs. Putting aside appeals by brand name firms for the need for funding for research and development (which does not apply to generics), the most attractive explanation for why brand nme drug makers can increase prices is because they can.

AstraZeneca settles Texas drug suits for $110 million

Texas accused the pharmaceutical giant of promoting its antipsychotic drug Seroquel to Texas Medicaid providers for unapproved uses, and for misrepresenting the benefits of its cholesterol medication Crestor.

These are the Fortune 500 companies that call Philadelphia home

Philadelphia region is home to 12 companies that cracked the Fortune 500 list for 2018. And then there's Vanguard, plus the big hospital systems and universities.

AmerisourceBergen faces another federal subpoena over opioids

Drug distributor AmerisourceBergen says it received a subpoena from federal law enforcement over opioids, and reveals millions in legal costs linked to the opioid epidemic.

Merck CEO Kenneth Frazier, speaking in Philly, urges people to call out ‘untruth, misinformation, and just plain BS’

The Merck CEO, the first African American to lead a major pharmaceutical company, reprised why he left Trump's manufacturing advisory council last year. He also condemned the National Rifle Association and expressed despair and anger over school and church shootings and police brutality.

Clinical trial firm Greenphire partners with Lyft to give rides for patients testing experimental care

Greenphire, a financial software provider for clinical trials, is partnering with ride-share company Lyft to help clinical trial sites book rides for participants and reimburse them for any transportation costs.

Pa.’s $10M helps AmerisourceBergen decide on new Conshy HQ, with 550 new jobs

Drug distributor AmerisourceBergen said Wednesday it is planning a new headquarters in Conshohocken, Montgomery County, and will move 1,500 bosses and staff from its former Chesterbrook headquarters and a smaller Conshohocken office into a new, 12-story, 427,000-square-foot tower.

Bucks County to sue Big Pharma over opioid crisis

Since neighboring Delaware County became the first county in the state to sue pharmaceutical companies over the local costs of the opioid crisis last year, several other counties have followed suit; Bucks County is the latest to file a lawsuit against Big Pharma.

Retail
Beloved toy store FAO Schwarz makes its comeback

SPECIAL REPORTS
Investigative reports, featured series, and guides to living in the Philadelphia region, brought to you by The Inquirer.
WHAT ARE YOU CURIOUS ABOUT?
Send us your burning questions, or vote on other readers' questions that pique your interest. Our journalists will work to answer them.